Australia's largest stock trading and investment forum Australia's #1 stock forum

SP1

Click for more information

0.00%

$1.07 southern cross payments ltd

Ann: SP1 delisted from ASX, page-400

First 400 Last

Share
Profile

Follow
tothestars99

104 Posts.

54

09/11/22

15:40

Post #: 64674389
Share

Originally posted by naomhan: ↑

No, they didn't state they have "no issue" with the performance shares. That's intentionally misleading. I think the wording was "not challenging" the existence of the performance shares. There's a big difference.

However, they have decided that they'd pursue charges that the directors entered questionable, zero growth contracts that resulted in them claiming a third of the company in performance shares, while doing absolutely nothing to build value, and in doing so, failed to act in shareholder interests. You do realise that this is very different to "no issue" with the performance shares, right?

"A little bird". Everyone knows you're associated with the company. We all know that an ASIC team audited the financials before the suspension, and didn't find proof at the time, however they clearly had question marks, and further investigations continued (leading us to where we are today). You are, yet again, spinning things for the company. Half truths and shortcuts. That's what we've come to expect sadly.

Expand

Duh friend. What is the opposite of "issue".... lol

Sometimes you just need to apply kindy logic to come to the correct conclusion.

SP1 Price at posting: $1.07 Sentiment: Buy Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

LU7

The Breakdown: Lithium Universe talks financial modelling and lithium pricing in strong preliminary feasibility study for Bécancour

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ASX Market Open: Middle East tensions push oil higher and Wall Street lower, reverberating on the ASX200 | October 4, 2024

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 202 more messages in this thread...

First 400 Last

Add SP1 (ASX) to my watchlist